CD19 and lymphoma: We observed that CD57+ TFH frequency positively correlated with advanced age (Fig. 5I) as well as the number of CD19+ lymphoma cells in FL (Fig. 5J), consistent with the finding that CD57+ TFH cells were highly represented in the CD19+ B cell enriched patient group (G3).